Business Description
Centogene NV
NAICS : 621512
SIC : 8099
ISIN : NL0014040206
Share Class Description:
FRA:39K: Ordinary SharesDescription
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | -0.21 | |||||
| Debt-to-Equity | -3.94 | |||||
| Debt-to-EBITDA | -4.4 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.2 | |||||
| 3-Year EBITDA Growth Rate | -5.9 | |||||
| 3-Year EPS without NRI Growth Rate | -4 | |||||
| 3-Year FCF Growth Rate | -2.8 | |||||
| 3-Year Book Growth Rate | -56.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.66 | |||||
| 9-Day RSI | 24.66 | |||||
| 14-Day RSI | 29.21 | |||||
| 6-1 Month Momentum % | -39.15 | |||||
| 12-1 Month Momentum % | -9.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.45 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 56.32 | |||||
| Days Sales Outstanding | 264.58 | |||||
| Days Payable | 166.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.6 | |||||
| Shareholder Yield % | -327.76 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.4 | |||||
| Operating Margin % | -102.96 | |||||
| Net Margin % | -77.89 | |||||
| FCF Margin % | -75 | |||||
| ROE % | -396.74 | |||||
| ROA % | -19.97 | |||||
| ROIC % | -42.24 | |||||
| ROC (Joel Greenblatt) % | -71.95 | |||||
| ROCE % | -33.21 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.49 | |||||
| EV-to-EBIT | -2.91 | |||||
| EV-to-EBITDA | -4.19 | |||||
| EV-to-Revenue | 2.67 | |||||
| EV-to-Forward-Revenue | 1.03 | |||||
| EV-to-FCF | -3.51 | |||||
| Earnings Yield (Greenblatt) % | -34.39 | |||||
| FCF Yield % | -133.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Centogene NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 21.525 | ||
| EPS (TTM) (€) | -0.66 | ||
| Beta | -0.49 | ||
| Volatility % | 103.02 | ||
| 14-Day RSI | 29.21 | ||
| 14-Day ATR (€) | 0.042759 | ||
| 20-Day SMA (€) | 0.573325 | ||
| 12-1 Month Momentum % | -9.37 | ||
| 52-Week Range (€) | 0.388 - 1.98 | ||
| Shares Outstanding (Mil) | 27.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Centogene NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Centogene NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Centogene NV Frequently Asked Questions
What is Centogene NV(FRA:39K)'s stock price today?
The current price of FRA:39K is €0.39. The 52 week high of FRA:39K is €1.98 and 52 week low is €0.39.
When is next earnings date of Centogene NV(FRA:39K)?
The next earnings date of Centogene NV(FRA:39K) is 2024-05-31 Est..
Does Centogene NV(FRA:39K) pay dividends? If so, how much?
Centogene NV(FRA:39K) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers